HALO vs RGEN: stock comparison and AI forecast
Halozyme Therapeutics, Inc. (HALO) and Repligen Corp (RGEN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
HALO Halozyme Therapeutics, Inc.
- Market Cap
- $14.86B
- P/E Ratio
- 30.1x
- Size
- large-cap
- AI Forecast
RGEN Repligen Corp
- Market Cap
- $11.06B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- HALO is 1.3 times larger than RGEN by market capitalization ($14.86B against $11.06B).
- HALO carries 16.96 times debt per unit of equity, against 0.40 times for RGEN.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | HALO | RGEN |
|---|---|---|
| Market Cap | $14.86B | $11.06B |
| P/E Ratio | 30.09x | – |
| P/B Ratio | 103.51x | 5.29x |
| EPS | $4.35 | $-0.08 |
| Book Value/Share | $1.26 | $32.71 |
| Revenue/Share | $14.66 | $12.60 |
| FCF/Share | $7.10 | $1.67 |
Profitability & Margins
| Metric | HALO | RGEN |
|---|---|---|
| ROE | 288.1% | – |
| ROA | 16.1% | – |
| ROIC | 26.7% | 0.7% |
| Gross Margin | 82.4% | 53.8% |
| Operating Margin | 35.9% | 2.3% |
| Net Margin | 24.9% | – |
| EBT Margin | 35.1% | 1.0% |
| Tax Rate | 29.1% | 243.4% |
Financial Health
| Metric | HALO | RGEN |
|---|---|---|
| Current Ratio | 2.71x | 9.88x |
| Quick Ratio | 2.31x | 8.43x |
| D/E Ratio | 16.96x | 0.40x |
| Financial Leverage | 17.96x | 1.40x |
| Working Capital | $589M | $1.12B |
Cash Flow
| Metric | HALO | RGEN |
|---|---|---|
| Operating Cash Flow | $819M | $130M |
| Free Cash Flow | $806M | $107M |
| Capital Spending | -$12M | -$23M |
| OCF Growth YoY | 49.4% | -0.8% |
| FCF Growth YoY | 49.1% | -3.0% |
| FCF/Sales | 48.5% | 13.2% |
| CapEx/Sales | 0.7% | 2.9% |
Operational Efficiency
| Metric | HALO | RGEN |
|---|---|---|
| Asset Turnover | 0.65x | 0.28x |
| Receivables Turnover | 3.7x | 5.3x |
| Inventory Turnover | 2.1x | 2.0x |
| Fixed Assets Turnover | 33.4x | 4.9x |
| Days Sales Outstanding | 99 days | 69 days |
| Days Inventory | 171 days | 179 days |
| Payables Period | 29 days | 27 days |
| Cash Conversion Cycle | 241 days | 220 days |
Income Statement
| Metric | HALO | RGEN |
|---|---|---|
| Total Revenue | $1.66B | $806M |
| Operating Income | $597M | $18M |
| Net Income | $414M | – |
| R&D Expense | $102M | $56M |
| SG&A Expense | $238M | $311M |
| Cost of Goods Sold | $292M | $372M |
Dividend & Shareholder Information
| Metric | HALO | RGEN |
|---|---|---|
| Shares Outstanding | 114M | 64M |
| Net Income Growth | -25.8% | – |
| EPS Growth | 7.7% | – |
HALO vs RGEN: stock comparison and AI forecast
Which is bigger, HALO or RGEN?
HALO is 1.3 times larger than RGEN by market capitalization ($14.86B against $11.06B).
Which one does Intratio's AI model rank higher, HALO or RGEN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.